ZA848501B - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- ZA848501B ZA848501B ZA848501A ZA848501A ZA848501B ZA 848501 B ZA848501 B ZA 848501B ZA 848501 A ZA848501 A ZA 848501A ZA 848501 A ZA848501 A ZA 848501A ZA 848501 B ZA848501 B ZA 848501B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/69—Two or more oxygen atoms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/30—Oligoelements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
- C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Inorganic Chemistry (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB838329043A GB8329043D0 (en) | 1983-10-31 | 1983-10-31 | Pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA848501B true ZA848501B (en) | 1986-06-25 |
Family
ID=10551002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA848501A ZA848501B (en) | 1983-10-31 | 1984-10-31 | Pharmaceutical compositions |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US4665064A (xx) |
| EP (1) | EP0145228B1 (xx) |
| JP (1) | JPH0655722B2 (xx) |
| AU (1) | AU584590B2 (xx) |
| CA (1) | CA1290096C (xx) |
| CY (1) | CY1678A (xx) |
| DE (1) | DE3484098D1 (xx) |
| DK (1) | DK162840C (xx) |
| GB (2) | GB8329043D0 (xx) |
| HK (1) | HK97492A (xx) |
| IE (1) | IE57801B1 (xx) |
| IL (1) | IL73379A (xx) |
| NZ (1) | NZ210057A (xx) |
| PH (1) | PH27408A (xx) |
| SG (1) | SG101992G (xx) |
| ZA (1) | ZA848501B (xx) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8606913D0 (en) * | 1986-03-20 | 1986-04-23 | Hider R C | Treatment of sickle cell disease |
| CA1283404C (en) * | 1986-07-01 | 1991-04-23 | Shigeru Sanai | Cephalosporin compounds, processes for their preparation and antibacterial agents |
| US4908371A (en) * | 1987-11-10 | 1990-03-13 | Ciba-Geigy Corporation | Esterified hydroxy dihydropyridinones for treating diseases associated with trivalent metal ion overload |
| US6004951A (en) * | 1989-11-22 | 1999-12-21 | Bernstein; Lawrence Richard | Administration of gallium complexes of 3-hydroxy-4-pyrones to provide physiologically active gallium levels in a mammalian individual |
| US5258376A (en) * | 1989-11-22 | 1993-11-02 | Bernstein Lawrence R | Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones |
| US5574027A (en) * | 1989-11-22 | 1996-11-12 | Bernstein; Lawrence R. | Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones |
| CA2122908C (en) * | 1991-11-12 | 2004-08-17 | Lawrence Richard Bernstein | Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones |
| JPH07111202B2 (ja) * | 1992-05-18 | 1995-11-29 | 株式会社ゼネラルエンジニアリング | ダブルピストン形トルクアクチュエータ |
| US5298525A (en) * | 1992-11-23 | 1994-03-29 | University Technologies International, Inc. | Diabetes prevention and treatment |
| US5372822A (en) * | 1994-03-07 | 1994-12-13 | Fahim; Mostafa S. | Chemical castration |
| EP0833627B1 (en) | 1995-06-10 | 2004-08-18 | Vitra Pharmaceuticals Ltd. | Iron compounds, compositions, methods of making the same and uses thereof |
| GB9621273D0 (en) | 1996-10-11 | 1996-11-27 | Cortecs Ltd | Therapeutic method |
| ID28630A (id) * | 1998-09-23 | 2001-06-21 | Unilever Nv | Komposisi-komposisi perawatan oral |
| US6767741B1 (en) * | 1999-08-27 | 2004-07-27 | Invitrogen Corporation | Metal binding compounds and their use in cell culture medium compositions |
| JP2001220348A (ja) * | 1999-11-30 | 2001-08-14 | Japan Science & Technology Corp | 亜鉛（ｉｉ）有機錯体からなる血糖降下剤 |
| DE19961256A1 (de) * | 1999-12-18 | 2001-06-21 | Clariant Gmbh | Kosmetische Zubereitungen |
| DE60107272T2 (de) * | 2000-09-19 | 2005-10-27 | Vitra Pharmaceuticals Ltd., Saffron Walden | Eisenverbindungen |
| GB0211500D0 (en) * | 2002-05-18 | 2002-06-26 | Vitra Pharmaceuticals Ltd | Method of forming iron hydroxypyrone compounds |
| US20060094777A1 (en) * | 2004-11-01 | 2006-05-04 | Westfall Geoffrey J | Teat disinfectant having zinc EDTA, and methods |
| CL2007002026A1 (es) * | 2006-07-13 | 2008-06-06 | Los Angeles Biomed Res Inst | Composicion que comprende al menos un compuesto quelante de hierro y al menos un agente antifungico; y metodo para el tratamiento o prevencion de una condicion fungica. |
| US8026261B2 (en) | 2007-03-28 | 2011-09-27 | Apotex Technologies Inc. | Fluorinated derivatives of deferiprone |
| DK2268282T3 (en) | 2008-04-25 | 2014-11-24 | Apotex Technologies Inc | Liquid formulation of deferiprone with pleasant taste |
| SI2448922T1 (sl) | 2009-07-03 | 2014-12-31 | Apotex Technologies Inc. | Fluorirani derivati 3-hidroksipiridin-4-onov |
| CN102028305B (zh) * | 2010-11-24 | 2013-11-27 | 湖南中烟工业有限责任公司 | 一类邻羟基酮类化合物的锌配合物的应用 |
| CN102010790B (zh) * | 2010-11-24 | 2012-09-19 | 湖南中烟工业有限责任公司 | 麦芽酚或乙基麦芽酚的锌配合物的应用 |
| US9339516B2 (en) * | 2011-05-06 | 2016-05-17 | Lankenau Institute For Medical Research | Compositions and methods for the prevention of esophageal cancer |
| WO2017106737A1 (en) | 2015-12-17 | 2017-06-22 | Hubbell Incorporated | Multi-function measuring instrument |
| GB2613378B (en) * | 2021-12-02 | 2023-12-27 | Envitec Ltd | Cyclone device |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB761171A (en) * | 1953-05-29 | 1956-11-14 | Olin Mathieson | Heavy-metal salts of 2-mercaptopyridine-1-oxides and methods of preparing same |
| US2904573A (en) * | 1957-05-06 | 1959-09-15 | Ortho Pharma Corp | Ferrous citrate complex |
| US3130204A (en) * | 1962-02-07 | 1964-04-21 | Pfizer & Co C | Preparation of gamma-pyrones |
| US3281366A (en) * | 1962-02-09 | 1966-10-25 | Procter & Gamble | Synergistic antibacterial compositions |
| US3236733A (en) * | 1963-09-05 | 1966-02-22 | Vanderbilt Co R T | Method of combatting dandruff with pyridinethiones metal salts detergent compositions |
| US3968118A (en) * | 1968-08-31 | 1976-07-06 | Hoechst Aktiengesellschaft | Process for the manufacture of 1-hydroxy-2-pyridones |
| US4018907A (en) * | 1975-08-25 | 1977-04-19 | General Foods Corporation | Coloring food with iron-complexes |
| US4225614A (en) * | 1977-12-21 | 1980-09-30 | Aktiebolaget Draco | Method of treatment for mucocutaneous herpes simplex infections |
| US4543213A (en) * | 1978-07-24 | 1985-09-24 | The United States Of America As Represented By The United States Department Of Energy | Process for preparing 2,3-dihydroxybenzoic acid amides of tetraazaalkanes and cycloalkanes |
| US4279936A (en) * | 1979-09-24 | 1981-07-21 | William Underwood Company | Maltol treated canned meat process |
| US4442305A (en) * | 1981-08-24 | 1984-04-10 | The United States Of America As Represented By The United States Department Of Energy | Polycatecholamide chelating agents |
| GB2117766B (en) * | 1982-03-24 | 1985-08-29 | Nat Res Dev | Pharmaceutical compositions |
| EP0094149B1 (en) * | 1982-03-24 | 1986-09-10 | National Research Development Corporation | Pharmaceutical compositions containing a complex of iron with n-substituted 3-hydroxypyrid-2-one or -4-one derivatives |
| GB2118176B (en) * | 1982-03-24 | 1985-12-04 | Nat Res Dev | Pharmaceutical compositions |
| GB2128998B (en) * | 1982-10-22 | 1986-07-16 | Nat Res Dev | Pharmaceutical compositions of iron complexes of 3 hydroxy-4-pyrone |
| GB8308054D0 (en) * | 1983-03-24 | 1983-05-05 | Hider R C | Pharmaceutical compositions |
| GB8308055D0 (en) * | 1983-03-24 | 1983-05-05 | Hider R C | Pharmaceutical compositions |
| GB8325496D0 (en) * | 1983-09-23 | 1983-10-26 | Hider R C | Pharmaceutical compositions |
| GB8410289D0 (en) * | 1984-04-19 | 1984-05-31 | Callingham B A | Pharmaceutical compositions |
-
1983
- 1983-10-31 GB GB838329043A patent/GB8329043D0/en active Pending
-
1984
- 1984-10-29 PH PH31382A patent/PH27408A/en unknown
- 1984-10-31 JP JP59231136A patent/JPH0655722B2/ja not_active Expired - Lifetime
- 1984-10-31 NZ NZ210057A patent/NZ210057A/xx unknown
- 1984-10-31 CA CA000466674A patent/CA1290096C/en not_active Expired - Lifetime
- 1984-10-31 GB GB08427485A patent/GB2148896B/en not_active Expired
- 1984-10-31 DE DE8484307511T patent/DE3484098D1/de not_active Expired - Lifetime
- 1984-10-31 AU AU34884/84A patent/AU584590B2/en not_active Ceased
- 1984-10-31 ZA ZA848501A patent/ZA848501B/xx unknown
- 1984-10-31 IL IL73379A patent/IL73379A/xx not_active IP Right Cessation
- 1984-10-31 DK DK518984A patent/DK162840C/da not_active IP Right Cessation
- 1984-10-31 IE IE2799/84A patent/IE57801B1/en not_active IP Right Cessation
- 1984-10-31 US US06/666,905 patent/US4665064A/en not_active Expired - Lifetime
- 1984-10-31 EP EP84307511A patent/EP0145228B1/en not_active Expired - Lifetime
-
1987
- 1987-02-18 US US07/016,083 patent/US4894455A/en not_active Expired - Fee Related
-
1992
- 1992-10-17 SG SG1019/92A patent/SG101992G/en unknown
- 1992-12-03 HK HK974/92A patent/HK97492A/xx not_active IP Right Cessation
-
1993
- 1993-10-10 CY CY1678A patent/CY1678A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB8427485D0 (en) | 1984-12-05 |
| DK162840B (da) | 1991-12-16 |
| JPS60115564A (ja) | 1985-06-22 |
| IL73379A0 (en) | 1985-01-31 |
| US4665064A (en) | 1987-05-12 |
| DK518984D0 (da) | 1984-10-31 |
| SG101992G (en) | 1992-12-04 |
| GB2148896B (en) | 1987-07-29 |
| PH27408A (en) | 1993-06-21 |
| IE57801B1 (en) | 1993-04-07 |
| DK162840C (da) | 1992-05-04 |
| HK97492A (en) | 1992-12-11 |
| EP0145228A1 (en) | 1985-06-19 |
| AU3488484A (en) | 1985-05-09 |
| EP0145228B1 (en) | 1991-02-06 |
| JPH0655722B2 (ja) | 1994-07-27 |
| DK518984A (da) | 1985-05-01 |
| NZ210057A (en) | 1988-08-30 |
| CY1678A (en) | 1993-10-10 |
| US4894455A (en) | 1990-01-16 |
| CA1290096C (en) | 1991-10-01 |
| GB8329043D0 (en) | 1983-11-30 |
| IL73379A (en) | 1991-05-12 |
| IE842799L (en) | 1985-04-30 |
| DE3484098D1 (de) | 1991-03-14 |
| GB2148896A (en) | 1985-06-05 |
| AU584590B2 (en) | 1989-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2136807B (en) | Pharmaceutical compositions | |
| GB8423339D0 (en) | Pharmaceutical compositions | |
| GB8403668D0 (en) | Pharmaceutical compositions | |
| DE3467703D1 (en) | Pharmaceutical compositions | |
| GB8313217D0 (en) | Pharmaceutical compositions | |
| GB8415975D0 (en) | Pharmaceutical compositions | |
| GB8325494D0 (en) | Pharmaceutical compositions | |
| GB8308126D0 (en) | Pharmaceutical compositions | |
| GB8423800D0 (en) | Pharmaceutical compositions | |
| HK97492A (en) | Pharmaceutical compositions | |
| GB2136806B (en) | Pharmaceutical compositions | |
| GB8414458D0 (en) | Pharmaceutical compositions | |
| CY1503A (en) | Pharmaceutical compositions | |
| GB8323553D0 (en) | Pharmaceutical compositions | |
| GB8406132D0 (en) | Pharmaceutical compositions | |
| GB8419243D0 (en) | Pharmaceutical compositions | |
| GB8416358D0 (en) | Pharmaceutical compositions | |
| GB8305697D0 (en) | Pharmaceutical compositions | |
| GB8300767D0 (en) | Pharmaceutical compositions | |
| GB8425250D0 (en) | Pharmaceutical compositions | |
| GB2150435B (en) | Pharmaceutical compositions | |
| GB8317469D0 (en) | Pharmaceutical compositions | |
| GB8301718D0 (en) | Pharmaceutical compositions | |
| GB8304870D0 (en) | Pharmaceutical compositions | |
| GB8300012D0 (en) | Pharmaceutical compositions |